BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32230799)

  • 1. miR-216a Acts as a Negative Regulator of Breast Cancer by Modulating Stemness Properties and Tumor Microenvironment.
    Roscigno G; Cirella A; Affinito A; Quintavalle C; Scognamiglio I; Palma F; Ingenito F; Nuzzo S; De Micco F; Cuccuru A; Thomas R; Condorelli G
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-mobility group box 1 released by autophagic cancer-associated fibroblasts maintains the stemness of luminal breast cancer cells.
    Zhao XL; Lin Y; Jiang J; Tang Z; Yang S; Lu L; Liang Y; Liu X; Tan J; Hu XG; Niu Q; Fu WJ; Yan ZX; Guo DY; Ping YF; Wang JM; Zhang X; Kung HF; Bian XW; Yao XH
    J Pathol; 2017 Nov; 243(3):376-389. PubMed ID: 28802057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting LIN28B reprograms tumor glucose metabolism and acidic microenvironment to suppress cancer stemness and metastasis.
    Chen C; Bai L; Cao F; Wang S; He H; Song M; Chen H; Liu Y; Guo J; Si Q; Pan Y; Zhu R; Chuang TH; Xiang R; Luo Y
    Oncogene; 2019 Jun; 38(23):4527-4539. PubMed ID: 30742065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of miR-6844 alters stemness/self-renewal and cancer hallmark(s) markers through CD44-JAK2-STAT3 signaling axis in breast cancer stem-like cells.
    Prajapati KS; Kumar S
    J Cell Biochem; 2023 Aug; 124(8):1186-1202. PubMed ID: 37436061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts.
    Baroni S; Romero-Cordoba S; Plantamura I; Dugo M; D'Ippolito E; Cataldo A; Cosentino G; Angeloni V; Rossini A; Daidone MG; Iorio MV
    Cell Death Dis; 2016 Jul; 7(7):e2312. PubMed ID: 27468688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-216a-5p act as a tumor suppressor, regulating the cell proliferation and metastasis by targeting PAK2 in breast cancer.
    Zhang Y; Lin P; Zou JY; Zou G; Wang WZ; Liu YL; Zhao HW; Fang AP
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2469-2475. PubMed ID: 30964173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of miR-29b in carcinoma associated fibroblasts promotes cell growth and metastasis of breast cancer.
    Liu Y; Zhang J; Sun X; Su Q; You C
    Oncotarget; 2017 Jun; 8(24):39559-39570. PubMed ID: 28465475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer-derived exosomes regulate cell invasion and metastasis in breast cancer via miR-146a to activate cancer associated fibroblasts in tumor microenvironment.
    Yang SS; Ma S; Dou H; Liu F; Zhang SY; Jiang C; Xiao M; Huang YX
    Exp Cell Res; 2020 Jun; 391(2):111983. PubMed ID: 32268136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway.
    Zheng A; Song X; Zhang L; Zhao L; Mao X; Wei M; Jin F
    J Exp Clin Cancer Res; 2019 Jul; 38(1):305. PubMed ID: 31300015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-transcriptional repression of circadian component CLOCK regulates cancer-stemness in murine breast cancer cells.
    Ogino T; Matsunaga N; Tanaka T; Tanihara T; Terajima H; Yoshitane H; Fukada Y; Tsuruta A; Koyanagi S; Ohdo S
    Elife; 2021 Apr; 10():. PubMed ID: 33890571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer.
    Chen J; Shin VY; Siu MT; Ho JC; Cheuk I; Kwong A
    BMC Cancer; 2016 Nov; 16(1):887. PubMed ID: 27842518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer.
    Gwak JM; Kim HJ; Kim EJ; Chung YR; Yun S; Seo AN; Lee HJ; Park SY
    Breast Cancer Res Treat; 2014 Aug; 147(1):39-49. PubMed ID: 25086633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide analysis reveals miR-3184-5p and miR-181c-3p as a critical regulator for adipocytes-associated breast cancer.
    Rajarajan D; Selvarajan S; Charan Raja MR; Kar Mahapatra S; Kasiappan R
    J Cell Physiol; 2019 Aug; 234(10):17959-17974. PubMed ID: 30847933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
    Xia H; Ooi LL; Hui KM
    Hepatology; 2013 Aug; 58(2):629-41. PubMed ID: 23471579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-99a-5p suppresses breast cancer progression and cell-cycle pathway through downregulating CDC25A.
    Qin H; Liu W
    J Cell Physiol; 2019 Apr; 234(4):3526-3537. PubMed ID: 30443946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limonin attenuates the stemness of breast cancer cells via suppressing MIR216A methylation.
    Su Z; Wang C; Chang D; Zhu X; Sai C; Pei J
    Biomed Pharmacother; 2019 Apr; 112():108699. PubMed ID: 30970511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA MALAT1 mediates stem cell-like properties in human colorectal cancer cells by regulating miR-20b-5p/Oct4 axis.
    Tang D; Yang Z; Long F; Luo L; Yang B; Zhu R; Sang X; Cao G; Wang K
    J Cell Physiol; 2019 Nov; 234(11):20816-20828. PubMed ID: 31012108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor Suppressor miRNA-204-5p Regulates Growth, Metastasis, and Immune Microenvironment Remodeling in Breast Cancer.
    Hong BS; Ryu HS; Kim N; Kim J; Lee E; Moon H; Kim KH; Jin MS; Kwon NH; Kim S; Kim D; Chung DH; Jeong K; Kim K; Kim KY; Lee HB; Han W; Yun J; Kim JI; Noh DY; Moon HG
    Cancer Res; 2019 Apr; 79(7):1520-1534. PubMed ID: 30737233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Cellular Levels of MicroRNA-9 and MicroRNA-221 Correlate with Cancer Stemness and Predict Poor Outcome in Human Breast Cancer.
    Cheng CW; Yu JC; Hsieh YH; Liao WL; Shieh JC; Yao CC; Lee HJ; Chen PM; Wu PE; Shen CY
    Cell Physiol Biochem; 2018; 48(5):2205-2218. PubMed ID: 30110679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-216a inhibits the growth and metastasis of oral squamous cell carcinoma by targeting eukaryotic translation initiation factor 4B.
    Li L; Ma HQ
    Mol Med Rep; 2015 Aug; 12(2):3156-62. PubMed ID: 25955794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.